Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4515 Prognostic factors for survival in patients with metastatic small intestinal neuroendocrine tumours undergoing primary tumour resection

Introduction: Although guidelines recommend primary tumour resection in metastatic small intestinal neuroendocrine tumours (SI-NETs) to manage symptoms and complications, the survival benefit and optimal surgical approach remain unclear.

Conference:

Presenting Author:

Authors: Dell' Unto E, Ogunbiyi O, Mirnezami R, Malam Y, Yasin Y,

Keywords: Small Intestinal Neuroendocrine Tumour, surgery, midgut carcinoid,

#4457 Primary mixed hepatocellular carcinoma-neuroendocrine carcinoma: A case report

Introduction: Mixed epithelial neoplasms (MiNENs) are characterised by the coexistence of neuroendocrine and non-neuroendocrine components within a single tumour, each discernible histologically and immunohistochemically, with a minimum tumour proportion of 30%. Primary hepatic MiNENs are exceedingly rare entities.

Conference:

Presenting Author: Tang Y

Authors: Wang Y, Wang R, Yi X, Guo M, Tang Y,

Keywords: pancreatic neuroendocrine tumour, functional, parathyroid hormone related peptide,

#4307 Predictive value of pepsinogen I and I/II ratio for diagnosing autoimmune gastritis

Introduction: Autoimmune gastritis (AIG) is sometimes difficult to diagnose.

Conference:

Presenting Author:

Authors: Hu H, Chen C, Zhang Q, Li P,

Keywords: autoimmune gastritis, pepsinogen 1, pepsinogen 1/2 ratio, gastrin,

#3562 Prognostic factors in stage I-III adrenocortical cancer (ACC): Data of 230 patients from the ICARO_GETHI/SEEN registry

Introduction: The scientific evidence on adjuvant treatment of adrenocortical carcinoma (ACC) is scarce and based on a retrospective Italian-German series.

Conference:

Presenting Author: Jimenez-Fonseca P

Authors: Ballester I, Álvarez-Escolá C, Valdes N, Hernando J, Picon M,

Keywords: Adrenocortical cancer, Adjuvant treatment, Mitotane, Prognosis, Survival,

#412 Single Institutional Series of Neuroendocrine Tumors Managed in the Australian Capital Territory

Introduction: Neuroendocrine tumors (NETs) have been regarded as indolent tumors with significantly variable clinical behavior. Limited information is available on long-term clinical outcome and clinically applicable prognostic factors.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Malik L, Chua Y, Yip D, Butt N,

Keywords: neuroendocrine tumor,